Antipodes Partners’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
Other funds holding ABT
Antipodes Partners's ABT Position: Q2 2026 in Review
Antipodes Partners opened a new position in Abbott (ABT) in Q2 2026: 734 shares worth $66.6K. The stake represents ﹤0.01% of the portfolio and ranks #109 among its holdings. This is a return to the name: Antipodes Partners previously reported a position in ABT as recently as Q3 2025.
Antipodes Partners first reported a position in ABT in Q1 2025 and has held it in 4 quarters since. The position peaked at $168K in Q1 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Antipodes Partners held 734 shares of Abbott worth $66.6K as of Q2 2026.
- Abbott was a new Antipodes Partners position in Q2 2026.
- Abbott made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #109 holding.
- Antipodes Partners first reported a position in Abbott in Q1 2025 and has held it in 4 quarters since.
- Antipodes Partners's Abbott position peaked at $168K in Q1 2025.
- 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.